Загрузка...
HDAC10 as a potential therapeutic target in ovarian cancer
OBJECTIVE: We analyzed histone deacetylase 10 (HDAC10) for function in the context of the DNA damage response in BRCA1-null ovarian cancer cells as well as evaluated the potential of general HDAC inhibitors in primary ovarian carcinoma cells. HDAC10 had previously been shown to be highly stimulatory...
Сохранить в:
| Опубликовано в: : | Gynecol Oncol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6020686/ https://ncbi.nlm.nih.gov/pubmed/28073598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2017.01.009 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|